Horizon Therapeutics plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units. Horizon's global headquarters are in Dublin, Ireland.
The Company also has offices in Lake Forest, Ill.; Chicago, Ill.; Brisbane, Calif.; Novato, Calif.; Washington, D.C. and Mannheim, Germany.
Copyright West LLC. Minimum 15 minutes delayed.
May 8, 2019 at 8:00 AM EDT
Horizon Therapeutics First Quarter 2019 Earnings Call
Apr 29, 2019
Dr. R. Douglas’s AACE IR TED/OPTIC Presentation
Mar 11, 2019 at 12:00 PM EDT
Cowen and Company 39th Annual Health Care Conference
Feb 28, 2019 at 8:00 AM EST
Overview of Teprotumumab OPTIC Phase 3 Trial Topline Results and Thyroid Eye Disease (TED)
Feb 27, 2019 at 8:00 AM EST
Horizon Pharma Fourth Quarter 2018 Earnings Call